GridAI Technologies (GRDX) EBT (2015 - 2026)
GridAI Technologies' (GRDX) quarterly EBT came in at -$13.1 million in Q2 2026, down 1840.31% on a YoY basis from $752495.5 in Q2 2025, and down 223.66% quarter-over-quarter from -$4.0 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) EBT (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported EBT for 12 consecutive years, with -$13.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBT fell 1840.31% year-over-year to -$13.1 million; the trailing twelve-month figure through Jun 2026 stood at -$18.8 million (down 298.69% YoY), and the FY2025 full-year result was -$6.6 million, up 57.49% from the prior year.
- EBT slipped to -$13.1 million in Q2 2026 per GRDX's latest filing, from -$4.0 million in the prior quarter.
- Across five years, EBT topped out at $4.4 million in Q3 2022 and bottomed at -$13.1 million in Q2 2026.
- Historically, EBT has averaged -$3.8 million across 5 years, with a median of -$3.4 million in 2023.
- The sharpest annual moves came in 2022 and 2026: EBT soared 114.45% in 2022, then tumbled 1840.31% in 2026.
- Over 5 years, EBT stood at -$2.3 million in 2022, then plunged by 80.84% to -$4.1 million in 2023, then jumped by 71.05% to -$1.2 million in 2024, then slumped by 238.85% to -$4.0 million in 2025, then tumbled by 223.66% to -$13.1 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$13.1 million, -$4.0 million, and -$970856.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -294.56 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 | -13.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.10 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | -970,856.00 |
| Jun 30, 2025 | -674,931.00 |
| Mar 31, 2025 | -948,105.00 |
| Dec 31, 2024 | -1.19 Mn |
| Sep 30, 2024 | -1.90 Mn |
| Jun 30, 2024 | -3.43 Mn |
| Mar 31, 2024 | -9.10 Mn |
| Dec 31, 2023 | -4.13 Mn |
| Sep 30, 2023 | -3.43 Mn |
| Jun 30, 2023 | -4.19 Mn |
| Mar 31, 2023 | -4.07 Mn |
| Dec 31, 2022 | -2.28 Mn |
| Sep 30, 2022 | 4.39 Mn |
| Jun 30, 2022 | -5.41 Mn |
| Mar 31, 2022 | -9.39 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -30.40 Mn |
| Jun 30, 2021 | -9.28 Mn |